Keith A Cengel Selected Research

Keith A Cengel Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 08/2005
16	Malignant Mesothelioma 01/2021 - 09/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2012
10	Lung Neoplasms (Lung Cancer) 09/2020 - 05/2010
10	Mesothelioma 06/2020 - 09/2010
5	Radiation Pneumonitis 09/2020 - 09/2010
4	Inflammation (Inflammations) 01/2022 - 05/2010
4	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2008 - 02/2004
3	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2006
3	Pneumonia (Pneumonitis) 09/2020 - 12/2012
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 10/2005
3	Fibrosis (Cirrhosis) 04/2013 - 01/2009
3	Lung Injury 04/2013 - 01/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2012
2	Circulating Neoplastic Cells 01/2021 - 11/2018
2	Fibrosarcoma 06/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 03/2018 - 02/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 12/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2011 - 05/2010
2	Carcinogenesis 04/2007 - 02/2004
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Peritoneal Neoplasms 01/2020
1	Thymoma (Thymic Carcinoma) 01/2020
1	Esophagitis 01/2019
1	Dyspnea (Shortness of Breath) 01/2019
1	Supraventricular Tachycardia 01/2019
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 01/2019
1	Pain (Aches) 01/2019
1	Carcinoma in Situ 03/2018
1	Intraoperative Complications 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 08/2015
1	Hyperplasia 07/2015
1	Hemoptysis 12/2014
1	Osteoporosis 08/2013

Drug/Important Bio-Agent (IBA)

27	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 10/2005
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
6	Protons (Proton)IBA 08/2021 - 11/2010
5	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2020 - 12/2012
4	Oxygen (Dioxygen)IBA 06/2020 - 07/2011
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2007
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2009
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2020 - 12/2014
3	Monoclonal AntibodiesIBA 01/2020 - 11/2005
2	AcidsIBA 01/2022 - 03/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 08/2015
2	Singlet OxygenIBA 01/2017 - 12/2014
2	Photosensitizing Agents (Photosensitizers)IBA 08/2015 - 12/2014
2	Cetuximab (Erbitux)FDA Link 08/2015 - 10/2005
2	CytokinesIBA 04/2013 - 06/2011
2	Radioisotopes (Radionuclides)IBA 04/2013 - 06/2011
2	AntioxidantsIBA 12/2012 - 05/2010
2	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2007 - 09/2005
2	Dimethylallyltranstransferase (Dimethylallyltransferase)IBA 09/2005 - 08/2005
1	ProdrugsIBA 01/2022
1	MesothelinIBA 01/2021
1	AntigensIBA 01/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	LuminolIBA 01/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	AsbestosIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	Yttrium-90IBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Capecitabine (Xeloda)FDA Link 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 04/2017
1	cyclopropapyrroloindoleIBA 04/2017
1	Pemetrexed (MTA)FDA Link 03/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	Celecoxib (Celebrex)FDA Link 01/2016
1	Verteporfin (Visudyne)FDA Link 08/2015
1	Anabolic AgentsIBA 08/2013
1	Parathyroid Hormone (Parathormone)IBA 08/2013
1	ChemokinesIBA 04/2013

Therapy/Procedure

27	Radiotherapy 07/2021 - 02/2004
23	Photochemotherapy (Photodynamic Therapy) 01/2022 - 08/2008
18	Therapeutics 01/2022 - 02/2004
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2004
5	Proton Therapy 09/2020 - 01/2019
2	Immunotherapy 01/2021 - 04/2017
2	Particle Accelerators 09/2020 - 09/2020
2	Lasers (Laser) 01/2017 - 02/2014
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2020
1	Aftercare (After-Treatment) 01/2019
1	Contraindications 01/2018
1	Cranial Irradiation 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 04/2017
1	Transjugular Intrahepatic Portasystemic Shunt 01/2016